MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Evaluating the natural history of prodromal PD in the PARS cohort

    D. Jennings, A. Siderowf, M. Stern, K. Marek, PARS Study Investigators (New Haven, CT, USA)

    Objective: An objective of the Parkinson Associated Risk Syndrome (PARS) study is to identify a cohort 'at risk' for Parkinson's disease (PD) using sequential olfactory…
  • 2016 International Congress

    Midbrain atrophy differentially progresses between Richardson’s Syndrome, progressive supranuclear palsy-parkinsonism and Parkinson’s disease: Longitudinal MRI study

    Y.E. Huh, M. Hwang, J.K. Park, J.W. Cho (Seoul, Korea)

    Objective: To elucidate different patterns of progression in midbrain atrophy between patients with Richardson's syndrome (PSP-RS), progressive supranuclear palsy-parkinsonism (PSP-P), and Parkinson's disease (PD) using…
  • 2016 International Congress

    Application and correlates of the PSP quality of life scale

    L.A. Higginbotham, V. Johnson, A. Pantelyat (Baltimore, MD, USA)

    Objective: To apply the PSP Quality of Life scale (PSP-QoL) within a cross-sectional PSP population and correlate these scores with those of the PSP rating…
  • 2016 International Congress

    Three cases of neuronal intranuclear inclusion disease (NIID)

    Y. Miyamoto, Y. Morita, K. Furuta, Y. Osaki, H. Arahata, A. Watanabe, N. Fujii, T. Iwaki, H. Furuya (Kochi, Japan)

    Objective: Here, we present three NIID cases. One of them, autopsy was performed. Background: Neuronal intranuclear inclusion disease (NIID)(OMIM 603472) is a neurodegenerative disorder characterized…
  • 2016 International Congress

    A polysomnography study of REM sleep without atonia and REM sleep behavior disorder in MSA and PD

    C. Kaindlstorfer, G. Wenning, S. Bösch, B. Frauscher, F. Krismer, M. Nocker, G. Ransmayr, C. Scherfler, K. Seppi, A. Stefani, W. Poewe, B. Högl (Innsbruck, Austria)

    Objective: The aim of this study was to perform a cross-sectional comparative analysis of quantitative REM sleep without atonia (RWA) and REM sleep behavior disorder…
  • 2016 International Congress

    PROSPECT: A UK-based longitudinal observational study of PSP, CBD, MSA and atypical parkinsonism syndromes

    J. Woodside, R. Lamb, V. Chelban, D. Burn, A. Church, A. Gerhard, M. Hu, N. Leigh, J. Rowe, H. Houlden (London, United Kingdom)

    Objective: To aid the development of curative treatments, we need to develop better methods for diagnosing Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD) and Multiple…
  • 2016 International Congress

    The effects of fluvoxamine maleate in a post-natal stress rat model of neurodegeneration

    E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)

    Objective: In this study, we investigated whether treatment of anxiety-like symptoms with Fluvoxamine maleate alleviates the neurotoxic effects of 6-OHDA in a Parkinsonian rat model.…
  • 2016 International Congress

    Systematic literature review of droxidopa in clinical trials for neurogenic orthostatic hypotension (nOH) in parkinsonism

    S. Tashiro, K. Dashtipour, J.J. Chen, K. Frei, E. Rashidian (Loma Linda, CA, USA)

    Objective: The aim of this study was to review the published evidence for the efficacy, safety, and dosing practices of droxidopa treatment for symptomatic neurogenic…
  • 2016 International Congress

    Could smell test differ from scans without evidence of dopaminergic deficit and Parkinson’s disease?

    S.J. Kang, J.Y. Ahn, H.T. Kim (Seoul, Korea)

    Objective: To investigate the differences and similarities between SWEDD patients and PD patients using smell test. Background: The concept of SWEDD(scans without evidence of dopaminergic…
  • 2016 International Congress

    Olfactory testing in differential diagnosis of atypical essential tremor and tremor-dominant Parkinson’s disease

    O. Izhboldina, I. Zhukova, N. Zhukova, V. Alifirova, A. Latypova, M. Nikitina, Y. Mironova (Tomsk, Russia)

    Objective: The aim of this study was to assess olfactory function using Sniffing Sticks Test in groups of patients with Parkinson's disease, and atypical extrapyramidal…
  • « Previous Page
  • 1
  • …
  • 196
  • 197
  • 198
  • 199
  • 200
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley